Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents		$ 60,181	$ 105,597
Marketable securities		187,039	264,930
Prepaid expenses and other current assets		13,719	9,067
Total current assets		260,939	379,594
Restricted cash		1,585	1,690
Marketable securities, non-current		0	13,014
Other investments		19,000	19,000
Property and equipment, net		34,771	48,200
Operating lease right-of-use assets		18,871	24,739
Other non-current assets		4,886	4,622
Total assets		340,052	490,859
Current liabilities:
Accounts payable		2,893	5,366
Accrued liabilities and other current liabilities		46,519	40,822
Contingent consideration payable		0	7,600
Total current liabilities		49,412	53,788
Operating lease liabilities, non-current		41,921	50,994
Other non-current liabilities		517	3,253
Total liabilities		91,850	108,035
Commitments and contingencies (Note 18)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000 shares authorized at December 31, 2025 and 2024, respectively; no shares issued and outstanding at December 31, 2025 and 2024		0	0
Common stock, $0.0001 par value; 500,000 shares authorized at December 31, 2025 and 2024, respectively; 21,251 and 14,744 shares issued and outstanding at December 31, 2025 and 2024, respectively	[1]	2	1
Additional paid-in capital	[1]	1,867,512	1,727,638
Accumulated other comprehensive income		242	291
Accumulated deficit		(1,619,554)	(1,345,106)
Total stockholders’ equity		248,202	382,824	[2]
Total liabilities and stockholders’ equity		$ 340,052	$ 490,859

[1] 1. Amounts previously reported have been retroactively adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2.

[2] 1. Amounts previously reported have been retroactively adjusted to reflect the 1-for-20 reverse stock split effected on May 30, 2025. See Note 2